eniferBio and Skretting continue feed trials

Skretting and eniferbio are strengthening their partnership after signing an agreement that outlies further testing of eniferBio’s PEKILO protein for Atlantic salmon and rainbow trout feed.

The Fish Site
by The Fish Site
27 September 2022, at 1:22pm
group shot
Skretting is testing eniferBio's PEKILO protein as a sustainable aquafeed ingredient

Photo (left to right): Heikki Keskitalo (eniferBio), Ana Ward (Nutreco), Gunvor Baardsen (Skretting), Mette Lütcherath (Skretting), Joost Matthijssen (Nutreco), Erik Tveteraas (Nutreco), Joosu Kuivanen (eniferBio)

Skretting and eniferBio have signed a memorandum of understanding (MoU) on continued cooperation. The biotech start-up was the winner of the 2020 Nutreco Feed & Food Tech Challenge. This biannual competition acknowledges the best breakthrough innovations within livestock farming, aquaculture and alternative food proteins. The first prize included a scientific validation trial.

The first performance tests on PEKILO with Atlantic salmon were run in 2021 with promising results. In unison with the signing of the agreement, eniferBio has now provided a new batch of PEKILO protein for the next phases of testing its performance as aqua feed with Atlantic salmon and the first performance testing rounds with rainbow trout. Mette Lütcherath, category manager novel ingredients at Nutreco says, “the MoU defines the next steps towards commercialisation of PEKILO protein and implementation into Skretting feeds, in line with our sustainability ambitions of including 5–10 percent of novel ingredients into our formulations by 2025. There is a strong intention from both parties to reach large commercial volumes of this low carbon, high protein novel raw material; first in Europe and subsequently in other geographies.”

“Skretting is a leading manufacturer and supplier of aquaculture feeds, so it is significant to get help from a major company like them in getting our innovation out there. We are thrilled that the first round of performance tests was a success, and we can continue the partnership,” adds Joosu Kuivanen, COO and co-founder of eniferBio.